NewAmsterdam Pharma Co N.V. (NAMS) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $246.0K | -63.4% |
| 2024 | $672.0K | +2700.0% |
| 2023 | $24.0K | -89.1% |
| 2022 | $221.0K | +820.8% |
| 2021 | $24.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $246.0K | -63.4% |
| 2024 | $672.0K | +2700.0% |
| 2023 | $24.0K | -89.1% |
| 2022 | $221.0K | +820.8% |
| 2021 | $24.0K | — |